Hence the company in this case would be silly if they were not garnering this opportunity. Hope that helps.
Well.. thats my point.. why are they not spending on R&D? we are a month away from Financial Year End and these guys spent $37,000 on research for the year?
If you have Netflix... go watch Dirty Money with the episode on Valeant Pharmaceuticals.... NOT SAYING its the same here... but it gives you an idea how manipulative things can get in the market... Its all about "making deals"...
- Forums
- ASX - By Stock
- CPH
- Ann: Quarterly Update & Appendix 4C
Ann: Quarterly Update & Appendix 4C, page-60
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online